Wegovy injections at home: what the drama actually reveals

What did @annieandabby actually say?

There are no medical claims in this video. What you get is about three minutes of chaotic family footage: a mother on Wegovy who couldn't self-inject, handed the pen to her 11-year-old daughter Abby, and filmed the whole anxious ordeal. The creator says "I'm not a freaking nurse" and at one point worries aloud, "What if I have side effects from this? What if I die?" No dosing advice, no efficacy claims, just a genuinely stressed person struggling with needle anxiety and an auto-injector she hasn't fully figured out how to use.

The injection apparently failed on the first attempt. The daughter said "it wouldn't go in" and described blood appearing at the site, suggesting the needle didn't seat properly. A second attempt appears to have worked, confirmed by a small red dot and a circle around it. The creator then wonders if she can even see the site because, in her words, "it's somewhere in there" under skin folds.

Does the science back this up?

Needle anxiety and self-injection failure are genuinely common problems, not personal weakness. Published data suggest this is a real barrier to GLP-1 adherence worth taking seriously, not laughing off.

A 2021 study by Brod et al. in Diabetes Therapy found that injection anxiety affects a significant portion of patients starting injectable therapies, with fear of needles being one of the top cited barriers to adherence. Wegovy (semaglutide 2.4 mg) uses a prefilled auto-injector pen designed for subcutaneous injection into the abdomen, thigh, or upper arm. The device is engineered to reduce user error, but it still requires the user to hold the pen firmly against the skin, press the button, and hold it in place for approximately 10 seconds to ensure full dose delivery. If the pen is not pressed firmly enough against the skin, the needle may not fully extend, which appears to be exactly what happened on the first attempt here.

Novo Nordisk's prescribing information for Wegovy specifies that the injection should be administered by the patient or a caregiver trained in injection technique. "Caregiver" in that context typically means an adult. There is no clinical guidance supporting having a child administer the injection unsupervised.

What did they get wrong (or right)?

Credit where it's due: the creator isn't spreading misinformation. She's not claiming Wegovy cures anything, inventing a dosing protocol, or selling a stack. The anxiety she shows is real and relatable, and there's value in normalizing that injectable medications come with a learning curve.

That said, a few things in this video should have gone differently. First, having an 11-year-old administer a prescription injectable without demonstrated training is not a safe workaround for needle anxiety. Novo Nordisk's instructions for use explicitly describe a click-and-hold technique that requires consistent pressure. The failed first attempt, where the daughter said "it wouldn't go in," is consistent with incomplete needle deployment, which can result in a partial or missed dose. A partial dose of semaglutide is not a neutral event: you may still experience side effects without getting the full therapeutic effect.

Second, the comment "I can't see it because I'm so fat" points to a real clinical issue. Subcutaneous fat depth affects injection technique. In patients with larger body habitus, a 4mm or 5mm needle length may not reliably reach the subcutaneous layer in all injection sites, though the Wegovy pen is designed to address this. A trained provider should have walked this patient through site selection and technique before she left the pharmacy.

What should you actually know?

If you're on Wegovy or any injectable GLP-1 and struggling with self-injection, you have better options than handing the pen to a child and filming it.

• Ask your prescriber or pharmacist for an injection technique demonstration. This is a standard part of onboarding for injectables and most patients don't get it.
• If the needle didn't deploy fully and the medication is still visible in the reservoir window, the dose was not delivered. Do not attempt to re-inject immediately. Contact your prescriber or pharmacist for guidance on what to do with a missed or partial dose.
• Wegovy's auto-injector has a green indicator that appears when the injection is complete. The creator's family was looking for a red dot on the skin rather than checking the pen's dose indicator window, which is the correct confirmation method per Novo Nordisk's instructions for use.
• Needle anxiety is a documented clinical barrier. Cognitive behavioral strategies, topical anesthetics like EMLA cream, and structured injection training have evidence behind them. A 2019 review by McLenon and Rogers in Journal of Advanced Nursing found that multi-component interventions reduced injection anxiety meaningfully in adults.
• Children can legally serve as informal caregivers for injectable medications in some contexts, but this should involve formal training, not a TikTok learning curve.

The bottom line

This video is not dangerous misinformation. It is, however, an accidental tutorial in how not to administer a GLP-1 injectable: wrong confirmation method, undertrained administrator, possible missed dose, and no plan for what comes next. The creator's honesty about the chaos is refreshing. The execution needed a pharmacist, not a countdown.